LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04199052 |
Recruitment Status :
Recruiting
First Posted : December 13, 2019
Last Update Posted : January 17, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV/AIDS | Behavioral: LinkPositively | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 82 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care Across the Continuum for Black Women Affected by Interpersonal Violence |
Actual Study Start Date : | September 14, 2021 |
Estimated Primary Completion Date : | June 30, 2023 |
Estimated Study Completion Date : | October 31, 2023 |
Arm | Intervention/treatment |
---|---|
No Intervention: Standard of Care
Women assigned to the control arm will receive self-directed (non-Virtual Peer Navigator (PN) supported) treatment as usual at the HIV care service provider of choice following the Ryan White standard of care (i.e., referrals to physical, dental and mental health services; case management; and ancillary services. Annual assessments (e.g., updates on insurance, housing, referrals needed, behavioral assessment [e.g., depression, substance use]) are conducted by a case manager. For women who have fallen out of care and re-engage care, case management begins with an interview and assessment of current needs. Goals are set to create an individual care plan related to medical care, housing, and other resources, as needed. Referrals are made to appropriate services (e.g., primary care, housing, benefits counseling, food, support services) based on the intake assessment. It is important to note that the case management approach is self-guided versus intensive virtual PN assistance.
|
|
Experimental: LinkPositively Intervention
Women assigned to the LinkPositively intervention arm will have access to all four components of the LinkPositively app. Women will be scheduled for a session with staff to inform them of their assigned virtual Peer Navigator (PN). Staff will train participants on how to download the app, explain the five components, using each component, and contacting their PN. Within the first week after, virtual PNs will complete a one-on-one, in-person or phone intake session with the participant, based on the participant's preference. During this intake session, the PN will conduct a participant needs assessment to connect her to HIV medical care via local health clinics and identify other areas of need, services of need, and assisted referrals (domestic violence services, mental health care, substance abuse treatment, housing and legal support, etc.). PNs will provide trauma-informed emotional and informational support, including guidance on accessing information about referred services.
|
Behavioral: LinkPositively
LinkPositively is a culturally tailored, trauma-informed smartphone app for Black women living with HIV/AIDS affected by interpersonal violence. Core components of LinkPositively include: a) Virtual Peer Navigation that includes phone and text check-ins and 4 weekly one-on-one video sessions to build skills to cope with barriers and navigate care; b) Social Networking platform to receive peer support; c) Educational and Self-care database with healthy living and self-care tips; d) GPS-enabled Resource Locator for HIV care and ancillary support service agencies; and e) ART self-monitoring and reminder system. |
- Change in Retention in HIV Care [ Time Frame: 3 Months Post-Baseline ]Having two or more laboratory test for CD4 count AND/OR viral load at least 90 days apart
- Change in Retention in HIV Care [ Time Frame: 6 Months Post-Baseline ]Having two or more laboratory test for CD4 count AND/OR viral load at least 90 days apart
- Change in ART Adherence [ Time Frame: 3 Months Post-Baseline ]Greater or less than 90% adherence to ART regime measured by tenofovir (TFV), emtricitabine (FTC) concentration in hair samples
- Change in ART Adherence [ Time Frame: 6 Months Post-Baseline ]Greater or less than 90% adherence to ART regime measured by tenofovir (TFV), emtricitabine (FTC) concentration in hair samples
- Change in Viral Suppression [ Time Frame: 3 Months Post-Baseline ]Undetectable viral load OR fewer than 200 copies/mL
- Change in Viral Suppression [ Time Frame: 6 Months Post-Baseline ]Undetectable viral load OR fewer than 200 copies/mL

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Female gender identifying |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Female Gender
- Black or African-American racial/ethnic background
- Aged 18 years or older
- HIV-positive status
- Ever experienced physical, sexual, and/or psychological abuse by a current or former partner or non-partner (e.g., relative, friend, stranger)
- Owner of a smartphone with internet browsing capabilities
- English speaking
Exclusion Criteria:
- Male Gender
- Aged 17 or younger
- HIV-negative status

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04199052
Contact: Katherine M. Anderson, MPH | 619-471-3884 | k4anderson@health.ucsd.edu | |
Contact: Jamila K. Stockman, PhD, MPH | 858-822-4652 | jstockman@health.ucsd.edu |
United States, California | |
UCSD AntiViral Research Center | Recruiting |
San Diego, California, United States, 92103 | |
Contact: KATHERINE M ANDERSON, MPH 619-471-3884 k4anderson@ucsd.edu |
Principal Investigator: | Jamila K. Stockman, PhD, MPH | University of California, San Diego | |
Principal Investigator: | Keith J. Horvath, PhD | San Diego State University |
Responsible Party: | Jamila K. Stockman, Associate Professor, Vice Chief of Global Public Health, University of California, San Diego |
ClinicalTrials.gov Identifier: | NCT04199052 |
Other Study ID Numbers: |
191398 R34MH122014-01 ( U.S. NIH Grant/Contract ) |
First Posted: | December 13, 2019 Key Record Dates |
Last Update Posted: | January 17, 2023 |
Last Verified: | January 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | No current plan |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
HIV Care Continuum, Mobile Apps |
Acquired Immunodeficiency Syndrome HIV Infections Blood-Borne Infections Communicable Diseases Infections Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Lentivirus Infections |
Retroviridae Infections RNA Virus Infections Virus Diseases Slow Virus Diseases Genital Diseases Urogenital Diseases Immunologic Deficiency Syndromes Immune System Diseases |